We are live on
!
Find out more
Allspring Global Investments Portfolio holdings
AUM
$59.7B
1-Year Est. Return
29.08%
This Fund
S&P 500
This Quarter
Est. Return
+11.19%
1 Year Est. Return
+29.08%
3 Year Est. Return
+84.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.6B
AUM Growth
+$2.1B
(+3.7%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-4.87%
Top 10 Holdings %
Top 10 Hldgs %
10.91%
Holding
2,994
New
111
Increased
928
Reduced
1,779
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Properties
BXP
|
+$157M |
| 2 |
Synopsys
SNPS
|
+$129M |
| 3 |
Match Group
MTCH
|
+$120M |
| 4 |
Teleflex
TFX
|
+$96.4M |
| 5 |
Progressive
PGR
|
+$73.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$253M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$211M |
| 4 |
Amazon
AMZN
|
+$184M |
| 5 |
Universal Health Services
UHS
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.26% |
| 2 | Industrials | 12.75% |
| 3 | Healthcare | 12.64% |
| 4 | Financials | 12.45% |
| 5 | Consumer Discretionary | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
ANI Pharmaceuticals
ANIP
$1.73B
| $2.9K | ﹤0.01% |
72
-2
| -3% | -$75 |
|
2827
PVH
PVH
$3.76B
| $2.82K | ﹤0.01% |
40
-955
| -96% | -$56.9K |
|
2828
Hydrofarm Holdings
HYFM
$8M
| $2.8K | ﹤0.01% |
180
-4
| -2% | -$91 |
|
2829
ThredUp
TDUP
$405M
| $2.77K | ﹤0.01% |
2,115
-47
| -2% | -$64 |
|
|
SNBR
2830
DELISTED
Sleep Number
SNBR
| $2.75K | ﹤0.01% |
106
+62
| +141% | +$1.88K |
|
2831
KKR & Co
KKR
$99.5B
| $2.74K | ﹤0.01% |
59
-19,156
| -100% | -$934K |
|
2832
Gulfport Energy Corp
GPOR
$3B
| $2.72K | ﹤0.01% |
37
-1,346
| -97% | -$111K |
|
|
BASE
2833
DELISTED
Couchbase
BASE
| $2.64K | ﹤0.01% |
199
-5
| -2% | -$65 |
|
2834
Markel Group
MKL
$22.8B
| $2.63K | ﹤0.01% |
2
-2
| -50% | -$2.47K |
|
2835
Motorcar Parts of America
MPAA
$230M
| $2.63K | ﹤0.01% |
+222
| New | +$3.23K |
|
2836
ING
ING
$102B
| $2.62K | ﹤0.01% |
215
| – | – |
|
2837
Bioventus
BVS
$1.17B
| $2.59K | ﹤0.01% |
993
-94,177
| -99% | -$411K |
|
|
TTCF
2838
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $2.55K | ﹤0.01% |
2,072
-46
| -2% | -$136 |
|
|
ESPR
2839
DELISTED
Esperion Therapeutics
ESPR
| $2.53K | ﹤0.01% |
+406
| New | +$2.9K |
|
2840
Ternium
TX
$10.8B
| $2.44K | ﹤0.01% |
+80
| New | +$2.39K |
|
|
VERV
2841
DELISTED
Verve Therapeutics
VERV
| $2.42K | ﹤0.01% |
125
-3
| -2% | -$79 |
|
2842
Restaurant Brands International
QSR
$26.1B
| $2.39K | ﹤0.01% |
37
| – | – |
|
2843
Brookfield Asset Management
BAM
$87.1B
| $2.35K | ﹤0.01% |
+82
| New | +$2.47K |
|
|
CORZ
2844
DELISTED
Core Scientific, Inc. Common Stock
CORZ
| $2.34K | ﹤0.01% |
31,144
-681
| -2% | -$312 |
|
2845
Arbutus Biopharma
ABUS
$907M
| $2.33K | ﹤0.01% |
1,000
-22
| -2% | -$53 |
|
2846
Design Therapeutics
DSGN
$917M
| $2.06K | ﹤0.01% |
201
-5
| -2% | -$68 |
|
2847
Certara
CERT
$1.22B
| $2.06K | ﹤0.01% |
128
-7,096
| -98% | -$103K |
|
2848
Rivian
RIVN
$23.1B
| $1.95K | ﹤0.01% |
106
+53
| +100% | +$1.56K |
|
2849
Redwire
RDW
$3.37B
| $1.84K | ﹤0.01% |
928
-21
| -2% | -$48 |
|
2850
BrightView Holdings
BV
$1.08B
| $1.79K | ﹤0.01% |
+260
| New | +$2.01K |
|
Similar funds
QCM
NAMI
Allspring Global Investments's Q4 2022 Portfolio in Review
As of Q4 2022, Allspring Global Investments held 2,994 positions worth $58.6B, up 3.7% from $56.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Allspring Global Investments withdrew a net $2.85B in Q4 2022, closing 90 positions and reducing 1,779 holdings. Its most notable exit was Abiomed Inc, an estimated $61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Allspring Global Investments opened a new position in Watsco Inc worth $52.3M.
- Allspring Global Investments's largest Q4 2022 buy was Watsco Inc: 209,824 shares worth $52.3M.
- Allspring Global Investments added most to Boston Properties in Q4 2022, an estimated $157M increase.
- Allspring Global Investments's biggest Q4 2022 reduction was Humana, cutting an estimated $253M.
- Allspring Global Investments fully exited Abiomed Inc in Q4 2022, selling an estimated $61M.
- Allspring Global Investments's ten largest holdings make up 11% of its $58.6B portfolio in Q4 2022.
- Allspring Global Investments opened 111 new positions and closed 90 in Q4 2022.
- Allspring Global Investments's portfolio value rose 3.7% quarter-over-quarter to $58.6B.
Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.